Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 120 mg
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: povidone; croscarmellose sodium; titanium dioxide; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; macrogol 400; microcrystalline cellulose; hypromellose; iron oxide yellow; iron oxide red
Oral
10 - Not to be supplied before the effective date of the amendment to the Poisons Schedule, 5
Not Scheduled after consideration by Committee
Relief of symptoms associated with seasonal allergic rhinitis for adults and children aged 12 years and over.
Visual Identification: Peach, oblong, double convex tablet, debossed with "012" (underlined) on one side and a scripted ?e? on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2009-10-13